Sanguinate

GPTKB entity

Statements (13)
Predicate Object
gptkbp:instanceOf gptkb:company
gptkbp:clinicalTrialPhase Phase II
gptkbp:developedBy Prolong Pharmaceuticals
https://www.w3.org/2000/01/rdf-schema#label Sanguinate
gptkbp:industry gptkb:biotechnology
gptkbp:intendedUse treatment of anemia
treatment of sickle cell disease
gptkbp:mechanismOfAction oxygen transfer agent
gptkbp:productType oxygen therapeutic
gptkbp:routeOfAdministration intravenous
gptkbp:status investigational drug
gptkbp:bfsParent gptkb:Artificial_Blood
gptkbp:bfsLayer 8